Last reviewed · How we verify
NCT04492904
Singapore COVID-19 Chemosensory Tracking (SCCT) Study
trial testing Home-use Test and Follow-up Questionnaire in Covid19 in 102 participants. Completed in 15 June 2021.
15 June 2021
Quick facts
| Lead sponsor | Singapore Institute of Food and Biotechnology Innovation |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 102 |
| Start date | 17 July 2020 |
| Primary completion | 15 June 2021 |
| Estimated completion | 15 June 2021 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- Home-use Test and Follow-up Questionnaire
Conditions studied
- Covid19 — all drugs for Covid19 →
Sponsor
Singapore Institute of Food and Biotechnology Innovation
Who can join
Adults 21 to 70, any sex, with Covid19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims to longitudinally track the onset, severity and recovery of changes in chemosensory acuity (smell and/or taste loss) among those suspected of COVID-19 infection. Using standardised questionnaire and testing approaches, the investigators aim to objectively characterise and measure temporal changes in taste and smell to confirm the prevalence of these symptoms as an early marker of infection. Information on symptoms experience, changes in appetite and food-related quality of life will be also be assessed via questionnaire. The results of the study will help individuals who experience a loss of smell and/or taste to self-isolate and/or self-refer to a medical professional, if an association between smell and/or taste and COVID-19 infection is found.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Evaluating the Onset, Severity, and Recovery of Changes to Smell and Taste Associated With COVID-19 Infection in a Singaporean Population (the COVOSMIA-19 Trial): Protocol for a Prospective Case-Control Study.
Sheen F, Tan V, Haldar S, Sengupta S, et al · · 2020 · cited 4× · PMID 33351775 · DOI 10.2196/24797 -
The COVOSMIA-19 trial: Preliminary application of the Singapore smell and taste test to objectively measure smell and taste function with COVID-19.
Sheen F, Tan V, Lim AJ, Haldar S, et al · · 2022 · cited 3× · PMID 34848929 · DOI 10.1016/j.foodqual.2021.104482
Verify or expand the search:
- PubMed search for NCT04492904
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Covid19
Currently open trials in the same condition.
- NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
- NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
- NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
- NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
- NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting
Other Singapore Institute of Food and Biotechnology Innovation trials
Trials by the same sponsor.
- NCT07397754 — Sodium-rich COndiments Unifying Health and Taste · NA · recruiting
- NCT06691126 — Pharmacokinetic Study of Terpinolene in Healthy Subjects (PKT Study) · NA · completed
- NCT06421194 — Functional and Nutritional Plant-based Mixed Protein Study (FuN Protein Study) · NA · recruiting
- NCT06119035 — Insulin Modelling Based on Plasma Glucose Measures Via a Minimally-Invasive Glucose Sensor · NA · completed
- NCT06640335 — The Effects of Vegetable Preloading on Postprandial Glycemia, Insulinaemia and Gastric Emptying · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04492904 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Singapore Institute of Food and Biotechnology Innovation
- Last refreshed: 14 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04492904.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing